Universal hepatitis C testing during pregnancy and follow-up care
Universal HCV screening in pregnancy: Examining testing uptake and HCV care
['FUNDING_R01'] · WEILL MEDICAL COLL OF CORNELL UNIV · NIH-11195153
This project will see whether offering hepatitis C tests to all pregnant people leads to more testing and better follow-up care for mothers and their babies.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WEILL MEDICAL COLL OF CORNELL UNIV (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-11195153 on ClinicalTrials.gov |
What this research studies
If you are pregnant or recently gave birth, this research uses nationwide Medicaid and commercial insurance billing records to track who gets tested for hepatitis C and what care follows. The team will compare testing rates in pregnant people to non-pregnant people of reproductive age before and after the 2020 recommendation for universal pregnancy screening. They will also check whether more testing leads to more mothers getting linked to care and treatment after delivery and whether infants born to HCV-positive mothers receive appropriate testing and diagnosis. No clinic visits are required because the work analyzes existing insurance data from across the United States.
Who could benefit from this research
Good fit: People who are pregnant or recently postpartum—especially those covered by Medicaid or commercial insurance—and infants born to HCV-positive mothers are the groups this research focuses on.
Not a fit: People who are not pregnant, uninsured, or whose care is not captured in the included insurance claims data may not see direct benefits from this project.
Why it matters
Potential benefit: If successful, the results could help increase detection of hepatitis C in pregnancy, improve maternal linkage to treatment, and ensure infants at risk are identified earlier.
How similar studies have performed: Previous work and guideline changes suggested universal screening can increase detection in some settings, but evidence is limited on whether that leads to better postpartum treatment and infant testing, so this project addresses that gap.
Where this research is happening
NEW YORK, UNITED STATES
- WEILL MEDICAL COLL OF CORNELL UNIV — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KAPADIA, SHASHI — WEILL MEDICAL COLL OF CORNELL UNIV
- Study coordinator: KAPADIA, SHASHI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus